Onyia Jude's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Feb 14, 2025
- Accession no.
- 0000914475-25-000067
- Filed
- Feb 14, 2025
- Trade date
- Feb 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $336.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Onyia JudeCIK 0001894425 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +2,717 | $0.00 | $0 | 18,278 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −1,432 | $116.83 | −$167,300.56 | 16,846 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +2,690 | $0.00 | $0 | 19,536 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −1,447 | $116.75 | −$168,937.25 | 18,089 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +54,645 | $0.00 | $0 | 54,645 | Direct | |
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +10,241 | $0.00 | $0 | 10,241 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −2,717 | $0.00 | $0 | 5,434 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −2,690 | $0.00 | $0 | 8,070 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.